+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blepharitis Drug"

Blepharitis - Pipeline Insight, 2024 - Product Thumbnail Image

Blepharitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Blepharitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Blepharitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Blepharitis Drugs Market 2021-2025 - Product Thumbnail Image

Global Blepharitis Drugs Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
From
Blepharitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Blepharitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 63 Pages
  • Global
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Blepharitis is a common eye disorder that affects the eyelids and is characterized by inflammation, redness, and irritation. It is often caused by bacterial or fungal infections, allergies, or skin conditions. Treatment for blepharitis typically involves the use of topical medications, such as antibiotics, antifungals, and anti-inflammatory drugs. These medications are often used in combination with other treatments, such as warm compresses, lid scrubs, and eyelid hygiene. The Blepharitis Drug market is a segment of the larger Optical Disorders Drugs market. It is composed of a variety of medications used to treat blepharitis, including antibiotics, antifungals, and anti-inflammatory drugs. These medications are available in both prescription and over-the-counter forms. Some companies in the Blepharitis Drug market include Allergan, Bausch + Lomb, Merck, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more